Remove 2024 Remove Alpha Remove Marketability
article thumbnail

Alpha FMC completes acquisition of White Marble Consulting

Benzinga

05, 2024 (GLOBE NEWSWIRE) -- Alpha Financial Markets Consulting ("Alpha"), a leading global provider of specialist consulting services to the financial services industry, has acquired White Marble Consulting ("White Marble"), a specialist marketing consultancy firm to asset management, wealth management and alternatives clients.

Alpha 40
article thumbnail

Alpha Modus and Insight Acquisition Corp. Announce Effectiveness of Form S-4 Registration Statement for Proposed Business Combination

Benzinga

INAQ's Special Meeting of Stockholders to Approve the Business Combination Scheduled to be Held on October 14, 2024 CORNELIUS, N.C. 19, 2024 (GLOBE NEWSWIRE) -- Alpha Modus Corp. ("Alpha Modus"), a technology company with a core focus on artificial intelligence in retail, and Insight Acquisition Corp.

Alpha 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Age Alpha to Acquire Guggenheim Investments' Actively Managed Equity Funds Business

Benzinga

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Guggenheim Investments and New Age Alpha today announced a definitive agreement under which New Age Alpha will acquire Guggenheim Investments' actively managed equity funds business. billion out of Guggenheim Investments' more than $234 billion in total assets managed.

Alpha 40
article thumbnail

Plasma Fractionation Market to Surpass Market Valuation of USD 63.27 Billion by 2031 | SkyQuest Technology

Benzinga

30, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Plasma Fractionation Market will reach a value of USD 63.27 during the forecast period (2024-2031). Furthermore, it is expected that the growing usage of immunoglobulins and alpha-1-antitrypsin in different medical specialties worldwide will propel market expansion.

article thumbnail

OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million

Benzinga

04, 2024 (GLOBE NEWSWIRE) -- OnKure Therapeutics, Inc. With the PIKture-01 trial of OKI-219 well underway, we look forward to releasing early clinical data in the fourth quarter of 2024 and initiating planned combination arms of the PIKture-01 trial." and Reneo Pharmaceuticals, Inc. and Reneo Pharmaceuticals, Inc.

Alpha 45
article thumbnail

Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure

Benzinga

02, 2024 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. NASDAQ: RPHM ) ("Reneo") today announced the results of the special meeting of its stockholders held on September 26, 2024. The closing of the merger is anticipated to take place on or around Friday, October 4, 2024. to "OnKure Therapeutics, Inc."

Alpha 40
article thumbnail

The Sugar Daddy Effect? Assessing Corporate venture capital, Sovereign funds and Green Energy!

Musings on Markets

In keeping with my inability to stay focused, that then led me to also think about sovereign wealth funds, an increasingly powerful presence in both private and public equity markets, and then about green energy, a favored destination for impact investors over the last two decades.